Bonjour, Comment puis-je vous aider ?
DuPont de Nemours, Inc.
DuPont Closes Four Clean Water Technology
Extending world- class water purification capabilities to meet growing customer
WILMINGTON, Del., Jan . 9 , 2020 – DuPont (NYSE: DD) today announced it has completed the
2019 acquisitions of Desalitech, inge GmbH, Memcor ®, and OxyMem Limited; adding to its leading
portfolio of water purification and separation technologies, including ultrafiltration, reverse osmosis
and ion exchange resins.
These four recent acquisitions support DuPont’s goal to increase access to the products and
technologies needed to meet global customers’ current and future challenges, including the
increased need to recycle water while reducing the energy requirements to generate clean water .
“W ater sc arcity is a global challenge that needs to be solve d with a sense of urgency . As a global
leader in innovative water technologies, we are continually expanding our technology portfolio of
high -quality solutions to help our customers purify, conserve and reuse this precious resource,” said
HP Nanda, Global Vice President & General Manager, DuPont Water Solutions. “We look forward to
working with equipment manufacturers, end users and other value chain partners in a variety of
business models, solving their w ater challenges and delivering superior value.”
The recent acquisitions further broaden DuPont’s portfolio and enhance the company’s ability to
accelerate innovation and offer customers better levels of service, while reducing the life cycle costs
of clean water. The four companies being added to the DuPont Water Solutions portfolio include:
??q inge GmbH, an ultrafiltration membrane business acq uired from BASF. The industry-
leading, multi -bore PED ultrafiltration technology complements DuPont’s high- flow PVDF
membrane technology. The transaction included the business’ international workforce of
about 150 employees, its headquarters and production site in Greifenberg, Germany, and
associated intellectual property owned by BASF SE.
??q Memcor®, the ultrafiltration and membrane bioreactor (MBR) technologies division from
Evoqua Water Technologies Corp. The addition of the ultrafiltration portfolio broadens
DuPont’s solutions membrane bioreactors, submerged and pressurized ultrafiltration
systems, and other new applications. The transaction included a manufacturing facility in
Australia and about 200 employees.
??q Desalitech Ltd: a closed -circuit reverse osmosis (CCRO) company. Desalitech’s CCRO
technology addresses increasing needs for high water recovery in core market segments
such as food and beverage, municipal, microelectronics, power and others. The technology
adds to the Du Pont portfolio to help further reduce the life cycle cost of water, delivering
more than 95 percent recovery and making it easy for end users to operate in small - to
medium -sized systems in industrial and decentralized settings. The transaction included
the company (brands and product portfolio), intellectual property , and a 40-person
??q OxyMem Limited, a company that develops and produces Membrane Aerated Biofilm
Reactor (MABR) technology for the treatment and purification of municipal and industrial
wastewater. The transaction included all intellectual property, more than 6 0 employees
and one production site located in Athlone, Ireland.
With the addition of the inge and Memcor portfolios, DuPont becomes the leading UF supplier
across multiple market segments such as residential, industrial, utility, wastewater and other
specialty solutions . With the addition of CCRO from Desalitech, DuPont can provide customers
with more options and flexibility to solve water scarcity and purification challenges. With the
emerging technologies from OxyMem, the company can better support customers looking to
reduce footprint and energy requirements for secondary wastewater treatment.
“ These four acquisitions are absolutely aligned to our strategy to be the leading supplier of
water technologies to better serve evolving needs of our global customers ,” said Nicole
Richards, Director of Growth and Strategy, DuPont Water Solutions . “We look forward to
working with our customers and partners to increase access to the best new separation and
purification technologies to solve the global water cr isis together.”
About DuPont Safety & Construction
DuPont Safety & Construction is a global leader in delivering innovation for life’s essential needs in water,
shelter and safety; enabling its customers to win through unique capabilities, global scale and iconic
brands including DuPont™ Corian®, Kevlar®, Nomex®, Tyvek®, GreatStuff™, Styrofoam
FilmTec™. More on DuPont Water Solutions can be found at https://www.dupont.com/water
DuPont (NYS E: DD) is a global innovation leader with technology -based materials, ingredients and
solutions that help transform industries and everyday life. Our employees apply diverse science and
expertise to help customers advance their best ideas and deliver essential innovations in key markets
including electronics, transportation, construction, water, health and wellness, food and worker safety.
More information can be found at www.dupont.com
Cautionary Statement Regarding Forward Looking Statements This communication contains "forward- looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.
On April 1, 2019, the company completed the separation of its materials science business into a separate and independent publ ic company by way of a pro rata dividend-in-kind of all the then outstanding stock of Dow Inc. (the “Dow Distribution”). The company completed the separation of its agriculture business into a separate and independent public company on June 1, 2019, by way of a pro rata dividend- in-kind of all the then outstanding stock of Corteva, Inc. (the “Corteva Distribution”).
On December 15, 2019, DuPont and IIF announced they had entered definitive agreements to combine DuPont’s Nutrition & Biosciences business with IFF in a transaction that would result in IFF issuing shares to DuPont shareholders, pending customary closing conditions, other approvals including regulatory and that of IFF’s shareholders.
Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward -looking statements. Forward -looking statements are not guarantees of future resu lts. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward -looking statements include, but are not limited to: (i) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction with IFF; changes in relevant tax and other laws, (ii) failure to obtain neces sary regulatory approvals, approval, if required, of IFF’s shareholders, anticipated tax treatment or any required financing or to satisfy any of the other conditions to the proposed transaction, (iii) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects,
business and management strategies that could impact the value, timing or pursuit of the proposed transaction, (iv) risks and costs and pursuit and/or implementation of the separation of the N&B Business, including timing anticipated to complete the separation, any changes to the configuration of businesses included in the separation if implemented, (v) risks and costs related to the Dow Distribution and the Corteva Distribution (together, the “Distributions”) including with respect to achieving all expected benefits from the Distributions; restrictions under intellectual property cross license agreements; non- compete restrictions; incurrence of significant costs in connection with the Distributions, including costs to service debt incurred by the Company to establish the relative credit profiles of Corteva, Dow and DuPont and increased costs related to supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common co ntrol of DuPont; indemnification of certain legacy liabilities of E. I. du Pont de Nemours and Company ("Historical EID") in connection with the Corteva Distribution; and potential liability arising from fraudulent conveyance and similar laws in connection with the Distributions; (vii) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, rel ated to the transfer of certain levels of assets and businesses; (viii) uncertainty as to the long- term value of DuPont common stock; (ix) potential inability or reduced access to the capital markets or increased cost of borrowings, including as a result o f a credit rating downgrade and (x) other risks to DuPont's business, operations and results of operations including from: failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in politi cal conditions, including tariffs, trade disputes and retaliatory actions; impairment of goodwill or intangible assets; the availability of and fluctuations in the cost of energy and raw materials; business or supply disruption, including in connection with the Distributions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DuPont's intellectual property rights; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as m anagement's response to any of the aforementioned factors. These risks are and will be more fully discussed in DuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be a mended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present si gnificant additional obstacles to the realization of forward -looking statements. Consequences of material differences in results as compared with those anticipated in the forward -looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward -looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward -looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such for ward -looking statements is included in the section titled “Risk Factors” (Part II, Item 1A) of DuPont’s Quarterly Report on Form 10- Q for the period ended September 30, 2019 and its subsequent reports on Form 10- Q, 10- K and Form 8 -K.
# # #
1/ 9/20 20
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, 6S0@ or ® are
owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.
For further information contact:
+1 302- 996-8372